Construction of HSV-1 HF based replication defective vector

被引:0
|
作者
Xiang, Li [1 ]
Liu, Xinjing [1 ]
Liu, Huitao [1 ]
Han, Zhiqiang [1 ]
Lu, Jiameng [1 ]
Xu, Yuming [1 ]
机构
[1] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China
关键词
HSV-1; homologous recombination; replication defective vectors; SIMPLEX-VIRUS TYPE-1; DELETION MUTANTS; INFECTION; ICP27;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Due to the unique biological features of original virus, HSV-1 derived vectors are rendered a number of advantages, such as broad cell tropism, including infection non-dividing mammalian cells across a broad range of species, and large capacity for foreign gene delivery. To date, two types of recombinant HSV-1 vectors known as replication competent vector and replication defective vector, derived from different HSV-1 strains, such as strain KOS and strain 17 have been developed as gene delivery vehicles and applied in fundamental studies and clinical trials for gene therapy. However, so far, no HSV-1-HF strain derived recombinant vector has been reported yet. Since the features of HSV-1 vectors are largely associated their original virus strains, the HSV-1 vectors from different strains may vary in their infection ability, tropism and cytotoxicity. Here, we described the construction of a HSV-1-HF strain based replication defective vector by a homologous recombination approach in bacteria. [Li Xiang, Xinjing Liu, Huitao Liu, Zhiqiang Han, Jiameng Lu and Yuming Xu. Construction of HSV-1 HF based replication defective vector. Life Science Journal. 2011; 8(3):547-553] (ISSN: 1097-8135). http://www.lifesciencesite.com.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 50 条
  • [31] Replication-Defective HSV Vector Development for Targeted Gene Delivery
    Reinhart, Bonnie
    Leronni, Daniela
    Cohen, Justus B.
    Glorioso, Joseph C.
    MOLECULAR THERAPY, 2016, 24 : S48 - S48
  • [32] IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
    Johnson, Karen E.
    Bottero, Virginie
    Flaherty, Stephanie
    Dutta, Sujoy
    Singh, Vivek Vikram
    Chandran, Bala
    PLOS PATHOGENS, 2014, 10 (11)
  • [33] HSV-1’s contribution as a vector for gene therapy
    Alberto L. Epstein
    Nature Biotechnology, 2022, 40 : 1316 - 1316
  • [34] Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy
    W J Bowers
    J A Olschowka
    H J Federoff
    Gene Therapy, 2003, 10 : 941 - 945
  • [35] Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy
    Bowers, WJ
    Olschowka, JA
    Federoff, HJ
    GENE THERAPY, 2003, 10 (11) : 941 - 945
  • [36] HSV-1's contribution as a vector for gene therapy
    Epstein, Alberto L.
    NATURE BIOTECHNOLOGY, 2022, 40 (09) : 1316 - 1316
  • [37] Evaluation of HSV-1 and adenovirus vector-mediated infection, replication and cytotoxicity in lymphoma cell lines
    Zhang, Xudong
    Zhao, Lu
    Hang, Zhiqiang
    Guo, Hongqiang
    Zhang, Mingzhi
    ONCOLOGY REPORTS, 2011, 26 (03) : 637 - 644
  • [38] HSV-1 Vector-Based Assay To Identify Inhibitors of the Vanilloid Receptor
    Srinivasan, Rahul
    Wolfe, Darren
    Huang, Shaohua
    Krisky, David
    Sculptoreanu, Adrian
    Friedman, Peter A.
    de Groat, William C.
    Glorioso, Joseph C.
    MOLECULAR THERAPY, 2006, 13 : S63 - S64
  • [39] Neurotoxic reactions of CNS cells following gene transfer with defective herpes simplex virus (HSV-1) vector
    Sabel, BA
    Vick, A
    Hollt, V
    NEUROREPORT, 1995, 6 (18) : 2447 - 2449
  • [40] A DEFECTIVE HSV-1 VECTOR EXPRESSES ESCHERICHIA-COLI BETA-GALACTOSIDASE IN CULTURED PERIPHERAL NEURONS
    GELLER, AI
    BREAKEFIELD, XO
    SCIENCE, 1988, 241 (4873) : 1667 - 1669